Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AbbVie Collaboration with Neomorph to Develop Molecular Glue Degraders
Friday, January 24, 2025AbbVie and Neomorph have entered into a collaboration and licensing agreement to develop molecular glue degraders targeting multiple areas in oncology and immunology
MilliporeSigma Collaborates with Opentrons Labworks to Advance Laboratory Automation
Friday, January 24, 2025MilliporeSigma has entered into a multiyear collaboration with Opentrons Labworks The partnership aims to automate assay kits on a customised Opentrons Flex workstation supporting advancements in laboratory automation
IPA Innovates with AI to Develop Next-Generation GLP-1 Therapies for Diabetes Treatment
Thursday, January 23, 2025ImmunoPrecise Antibodies has created a new class of GLP therapies for type diabetes and obesity treatment developed entirely through artificial intelligence AI GLP drugs are widely used to manage type diabetes and obesity but often require frequent...
Zai Lab Secures Orphan Drug Designation from FDA for ZL-1310 in Small Cell Lung Cancer Treatment
Thursday, January 23, 2025Zai Lab has announced that the United States Food and Drug Administration FDA has awarded Orphan Drug Designation ODD to ZL a Deltalike ligand DLL antibodydrug conjugate ADC for the treatment of small cell lung cancer SCLC
Johnson & Johnson's SPRAVATO® (esketamine) Approved Monotherapy for Treatment-Resistant Depression
Wednesday, January 22, 2025Johnson Johnson has announced that the US Food and Drug Administration FDA has approved a supplemental New Drug Application sNDA for SPRAVATO esketamine CIII nasal spray
Dyne Therapeutics Secures FDA Fast Track Designation for DYNE-101 in Myotonic Dystrophy Type 1
Wednesday, January 22, 2025Dyne Therapeutics has received Fast Track designation from the US Food and Drug Administration FDA for its investigational therapy DYNE DYNE is an investigational therapy comprising an antisense oligonucleotide ASO conjugated to a fragment antibody F...
YolTech Begins Trial for YOLT-204 Gene Therapy in Beta-Thalassemia
Tuesday, January 21, 2025YolTech Therapeutics has announced the initiation of a clinical trial for YOLT an innovative therapy aimed at treating transfusiondependent betathalassemia TDT
Junshi Biosciences Partners with LEO Pharma for Toripalimab Distribution in Europe
Monday, January 20, 2025Shanghai Junshi Biosciences has entered a partnership with LEO Pharma for the distribution and marketing of its monoclonal antibody toripalimab across Europe
Zai Lab Announces Acceptance of KarXT NDA for Schizophrenia Treatment
Saturday, January 18, 2025Zai Lab has announced that Chinas National Medical Products Administration NMPA has accepted its New Drug Application NDA for KarXT a treatment for schizophrenia in adults
Arrowhead Pharmaceuticals Secures FDA Approval for Plozasiran to Treat Familial Chylomicronemia Syndrome
Saturday, January 18, 2025Arrowhead Pharmaceuticals has announced the acceptance of its New Drug Application NDA by the US Food and Drug Administration FDA for plozasiran an investigational RNA interference therapeutic for familial chylomicronemia syndrome FCS
